In an ideal scenario of an immune hemolytic anemia investigation, laboratory results would allow the identification of a causative agent, leading to proper patient treatment. However sometimes, laboratory findings do not bring the expected results, hence the importance of patient history. In this webinar, case studies will be presented where the test results are inconsistent with the patient clinical condition, leading to further investigations.
Carla Dinardo, MD, PhD,
Director at Fundação Pró‑Sangue São Paulo Hemocenter, Head of the Immunohematology Division, Director of External Relations Fundação Pró‑Sangue, and member of the Young Professional Council of ISBT, representing Latin America.
Carla Dinardo is the Director at Fundação Pró‑Sangue São Paulo Hemocenter and leads the Immunohematology Division. She graduated in medicine in 2005 and followed with a specialty in internal medicine (2006‑2008) and hematology and hemotherapy (2008‑2010). She began her career as a hemotherapist in 2012 as Head of the Immunohematology Division of Fundação Pró‑Sangue São Paulo Hemocenter. Since then, she has been involved in multiple projects involving blood group system genetics, red blood cell alloimmunization, and general transfusion practice. In the past four years she has served as the investigator in the NHLBI REDS III study in Brazil in collaboration with the Vitalant Research Institute in San Francisco. Since 2020, she has been the director of External Relations at the Fundação Pró‑Sangue and a member of the Young Professional Council of ISBT, representing Latin America.